- Home
- SKLZ vs NKTR Comparison
SKLZ vs NKTR Comparison
Compare SKLZ & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKLZ
- NKTR
- Stock Information
- Founded
- SKLZ 2012
- NKTR 1990
- Country
- SKLZ United States
- NKTR United States
- Employees
- SKLZ N/A
- NKTR N/A
- Industry
- SKLZ EDP Services
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- SKLZ Technology
- NKTR Health Care
- Exchange
- SKLZ Nasdaq
- NKTR Nasdaq
- Market Cap
- SKLZ 106.4M
- NKTR 108.3M
- IPO Year
- SKLZ N/A
- NKTR 1994
- Fundamental
- Price
- SKLZ $6.98
- NKTR $24.25
- Analyst Decision
- SKLZ Buy
- NKTR Strong Buy
- Analyst Count
- SKLZ 2
- NKTR 6
- Target Price
- SKLZ $10.75
- NKTR $81.67
- AVG Volume (30 Days)
- SKLZ 55.0K
- NKTR 4.8M
- Earning Date
- SKLZ 07-31-2025
- NKTR 08-07-2025
- Dividend Yield
- SKLZ N/A
- NKTR N/A
- EPS Growth
- SKLZ N/A
- NKTR N/A
- EPS
- SKLZ N/A
- NKTR N/A
- Revenue
- SKLZ $92,644,000.00
- NKTR $87,248,000.00
- Revenue This Year
- SKLZ $0.20
- NKTR N/A
- Revenue Next Year
- SKLZ $14.10
- NKTR N/A
- P/E Ratio
- SKLZ N/A
- NKTR N/A
- Revenue Growth
- SKLZ N/A
- NKTR N/A
- 52 Week Low
- SKLZ $3.54
- NKTR $6.48
- 52 Week High
- SKLZ $7.50
- NKTR $37.38
- Technical
- Relative Strength Index (RSI)
- SKLZ 63.13
- NKTR 63.40
- Support Level
- SKLZ $7.15
- NKTR $21.87
- Resistance Level
- SKLZ $7.50
- NKTR $26.59
- Average True Range (ATR)
- SKLZ 0.24
- NKTR 4.14
- MACD
- SKLZ 0.02
- NKTR 0.01
- Stochastic Oscillator
- SKLZ 72.35
- NKTR 54.77
About SKLZ Skillz Inc.
Skillz Inc is a mobile game development company. It is engaged in re-inventing competitive mobile gaming and thereby expanding the mobile gaming market. Some of the games available on its platform are Dominoes Gold, Blackout Bingo, 21 Blitz, and Solitaire Cube among others. The company's reportable business segments are; the Skillz segment and the Aarki segment. The majority of its revenue is generated from the Skillz segment which is an eSports gaming platform, enabling game developers to monetize their content through multi-player competition. Geographically, the company derives its key revenue from the United States and the rest from Israel, China, Malta, and other countries.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.